Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Byong Kim currently holds 25,000 shares of LIPELLA PHARMACEUTICALS INC. (LIPO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Byong Kim has been a net neutral trader of LIPO stock. They have purchased $0 and sold $0 worth of shares.
Byong Kim's most recent insider trade was on Mar 15, 2024, when they sold 25,000 shares at $0.00 per share.
Byong Kim serves as Executive at LIPELLA PHARMACEUTICALS INC. (LIPO). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Byong Kim holds the position of Executive at LIPELLA PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Byong Kim has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Byong Kim was on Mar 15, 2024, when they purchased $0 worth of LIPO shares. This transaction involved 25,000 shares at N/A per share.
Byong Kim currently owns 25,000 shares of LIPELLA PHARMACEUTICALS INC. (LIPO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Byong Kim's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Byong Kim has 1 Form 4 filings on record as an insider at LIPELLA PHARMACEUTICALS INC..
Set alerts for Byong Kim and 40,000+ other insiders.